Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hong

Showing results (1371-1380 of 1,404) with videos related to

Pageof 141
Sort By:
Cancer Research|February 2, 1999
Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomasW S Park, S M Dong, S Y Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancerRoy S Herbst, David H Johnson, Eric Mininberg, et al.
The Journal of Hospital Infection|May 4, 2010
Risk factors for device-associated infection related to organisational characteristics of intensive care units: findings from the Korean Nosocomial Infections Surveillance SystemY G Kwak, S-O Lee, H Y Kim, et al.
The Journal of Liquid Biopsy|September 22, 2025
Validation of a liquid biopsy assay with increased sensitivity for clinical comprehensive genomic profilingXavier S Bower, Jan Wignall, Matthew G Varga, et al.
Cancer|December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neckJ E Tseng, B S Glisson, F R Khuri, et al.
Open Forum Infectious Diseases|October 6, 2016
Diagnosis of <i>Capnocytophaga canimorsus</i> Sepsis by Whole-Genome Next-Generation SequencingMaria K Abril, Adam S Barnett, Kara Wegermann, et al.
The American Journal of Surgical Pathology|March 16, 2018
The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology StudyAlejandro A Gru, Jinah Kim, Melissa Pulitzer, et al.
Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.
Seminars in Oncology|August 15, 1998
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacementJ A Roth, S G Swisher, J A Merritt, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer developmentJean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Pageof 141

Showing results (1371-1380 of 1,404) with videos related to

Sort By:
Pageof 141
Cancer Research|February 2, 1999
Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomasW S Park, S M Dong, S Y Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancerRoy S Herbst, David H Johnson, Eric Mininberg, et al.
The Journal of Hospital Infection|May 4, 2010
Risk factors for device-associated infection related to organisational characteristics of intensive care units: findings from the Korean Nosocomial Infections Surveillance SystemY G Kwak, S-O Lee, H Y Kim, et al.
The Journal of Liquid Biopsy|September 22, 2025
Validation of a liquid biopsy assay with increased sensitivity for clinical comprehensive genomic profilingXavier S Bower, Jan Wignall, Matthew G Varga, et al.
Cancer|December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neckJ E Tseng, B S Glisson, F R Khuri, et al.
Open Forum Infectious Diseases|October 6, 2016
Diagnosis of <i>Capnocytophaga canimorsus</i> Sepsis by Whole-Genome Next-Generation SequencingMaria K Abril, Adam S Barnett, Kara Wegermann, et al.
The American Journal of Surgical Pathology|March 16, 2018
The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology StudyAlejandro A Gru, Jinah Kim, Melissa Pulitzer, et al.
Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.
Seminars in Oncology|August 15, 1998
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacementJ A Roth, S G Swisher, J A Merritt, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer developmentJean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Pageof 141